Guggenheim Downgrades Endava, Cites 3.4% Earnings Miss and Slowing Demand
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Guggenheim Securities lowered its investment rating on Endava PLC (NYSE: DAVA) from Buy to Neutral on May 27, 2026. The firm announced the decision following Endava’s third-quarter fiscal 2026 results, which missed revenue expectations by $4.5 million. The downgrade reflects concerns over decelerating revenue growth and a weakening macroeconomic environment for discretionary technology spending. Endava shares traded near $38.50 at the time of the announcement, representing a decline of over 22% from their 52-week high.
The downgrade marks a shift from Guggenheim’s six-year bullish stance on Endava, initiated with a Buy rating in June 2020. The last major rating downgrade for Endava occurred in November 2023 when Barclays moved to Equal Weight, citing valuation concerns after a 35% year-to-date rally. The current macro backdrop features elevated interest rates, with the US 10-year Treasury yield stabilizing near 4.5%, which pressures client budgets for digital transformation projects.
The immediate catalyst for Guggenheim’s action was Endava’s Q3 FY2026 earnings report released on May 26. The company reported revenue of £209.4 million, a 3.4% miss against consensus estimates. More critically, management commentary highlighted a continued slowdown in new bookings growth, particularly from financial services and technology sector clients. This sequential demand weakness triggered a reassessment of Endava’s near-term growth trajectory and valuation premium.
Endava’s Q3 FY2026 financial results revealed several pressure points. Revenue grew 11.2% year-over-year, a significant deceleration from the 24.5% growth rate reported in Q3 of the prior fiscal year. The company’s bookings growth rate slowed to 11%, down from 19% in the previous quarter. Operating margin compressed to 16.8%, compared to 18.2% a year earlier.
| Metric | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | £209.4M | £188.3M | +11.2% |
| Constant Currency Growth | 9.6% | 23.1% | -13.5 pts |
| Adjusted EPS | £0.62 | £0.68 | -8.8% |
| Headcount | 12,241 | 11,407 | +7.3% |
The stock’s year-to-date decline of 18% contrasts sharply with the 6% gain for the iShares Expanded Tech-Software Sector ETF (IGV) and the 8% rise in the S&P 500 over the same period. Endava’s market capitalization fell below $2.2 billion following the earnings release.
The downgrade signals a reevaluation of growth premiums across the IT consulting and services sector. Peers like Globant S.A. (GLOB) and EPAM Systems Inc. (EPAM) may face increased scrutiny on their forward guidance, particularly for financial services exposure. A sustained downturn could benefit lower-cost offshore providers like Tata Consultancy Services (TCS.NS) as clients prioritize cost savings over innovation.
A counter-argument is that Endava’s specialization in complex digital product engineering offers pricing power resilience not captured in near-term bookings. However, the risk of multiple compression is high if growth fails to re-accelerate in the next two quarters. Recent options flow shows a spike in put buying for June and July expiries, with open interest increasing 40% at the $35 strike. Hedge fund positioning data indicates a net increase in short interest over the past month, now representing 4.2% of float.
Investors will monitor Endava’s Q4 FY2026 earnings report, scheduled for late August 2026, for signs of booking stabilization. The next major catalyst is the company’s fiscal 2027 guidance, which will be scrutinized for growth assumptions in its key banking and payments vertical. Any commentary on pricing or utilization rates will be critical for margin forecasts.
Key technical levels include the $35.00 support zone, which aligns with the stock’s 2023 lows. A break below could target the $30 region. On the upside, the stock faces resistance near $42.50, its 50-day moving average. Sector sentiment will also hinge on the next Federal Open Market Committee decision on June 18, 2026, as rate cuts could alleviate budget pressure for Endava’s clients.
The downgrade highlights the sensitivity of high-growth IT services stocks to macroeconomic cycles. Retail investors should assess their exposure to companies with similar client concentration in cyclical sectors like financial services and technology. It underscores the importance of evaluating not just top-line growth but also the quality and visibility of future bookings, a metric often detailed in earnings supplements. For passive holders, monitoring the stock's reaction around its next earnings date is crucial.
Prior to Guggenheim's move, the analyst consensus was mixed. Barclays and J.P. Morgan already held Neutral or equivalent ratings. Guggenheim’s downgrade reduces the number of Buy ratings, potentially shifting the consensus price target lower. The average target price stood at $48 before this action, implying a 25% upside that now appears less certain. Investors can track subsequent analyst revisions for a clearer directional signal.
Following Barclays' downgrade to Equal Weight on November 7, 2023, Endava shares declined approximately 12% over the subsequent month. However, the stock recovered those losses within three months as the broader market rallied. Historical precedent suggests initial weakness is common, but the duration of underperformance depends on subsequent quarterly execution. The stock's reaction this time may be more pronounced given the concurrent earnings miss and slowing growth metrics.
Endava’s growth slowdown has eroded its valuation premium, prompting a key bull to step to the sidelines.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.